2014 Q2 Form 10-Q Financial Statement

#000119312514285005 Filed on July 30, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $230.3M $222.0M
YoY Change 3.73% 25.75%
Cost Of Revenue $125.0M $133.2M
YoY Change -6.16% 22.97%
Gross Profit $105.3M $88.83M
YoY Change 18.57% 30.16%
Gross Profit Margin 45.73% 40.01%
Selling, General & Admin $25.52M $23.27M
YoY Change 9.65% 33.61%
% of Gross Profit 24.23% 26.2%
Research & Development $10.80M $9.300M
YoY Change 16.13% -2.11%
% of Gross Profit 10.25% 10.47%
Depreciation & Amortization $7.400M $7.400M
YoY Change 0.0% 17.46%
% of Gross Profit 7.03% 8.33%
Operating Expenses $25.52M $23.27M
YoY Change 9.65% 33.61%
Operating Profit $68.95M $56.22M
YoY Change 22.66% 35.95%
Interest Expense $5.000K $6.000K
YoY Change -16.67% -33.33%
% of Operating Profit 0.01% 0.01%
Other Income/Expense, Net
YoY Change
Pretax Income $69.22M $56.38M
YoY Change 22.77% 36.11%
Income Tax $17.89M $13.45M
% Of Pretax Income 25.85% 23.86%
Net Earnings $51.32M $42.93M
YoY Change 19.56% 44.04%
Net Earnings / Revenue 22.28% 19.33%
Basic Earnings Per Share $1.27 $1.06
Diluted Earnings Per Share $1.27 $1.05
COMMON SHARES
Basic Shares Outstanding 40.33M shares 40.64M shares
Diluted Shares Outstanding 40.56M shares 40.82M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $342.6M $325.5M
YoY Change 5.25% 31.2%
Cash & Equivalents $342.6M $325.5M
Short-Term Investments
Other Short-Term Assets $26.61M $18.74M
YoY Change 42.02% -4.82%
Inventory $408.1M $376.6M
Prepaid Expenses
Receivables $316.9M $241.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.122B $987.2M
YoY Change 13.6% 15.87%
LONG-TERM ASSETS
Property, Plant & Equipment $316.3M $299.1M
YoY Change 5.75% 4.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.75M $10.18M
YoY Change 5.66% -10.71%
Total Long-Term Assets $327.0M $309.3M
YoY Change 5.75% 3.81%
TOTAL ASSETS
Total Short-Term Assets $1.122B $987.2M
Total Long-Term Assets $327.0M $309.3M
Total Assets $1.449B $1.296B
YoY Change 11.73% 12.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.01M $44.95M
YoY Change 22.38% 7.88%
Accrued Expenses $36.50M $39.20M
YoY Change -6.89% 5.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $169.4M $148.2M
YoY Change 14.29% -1.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $169.4M $148.2M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $179.0M $158.0M
YoY Change 13.29% -0.83%
SHAREHOLDERS EQUITY
Retained Earnings $1.164B $982.8M
YoY Change 18.42% 17.08%
Common Stock $109.6M $193.7M
YoY Change -43.43% 11.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.270B $1.138B
YoY Change
Total Liabilities & Shareholders Equity $1.449B $1.296B
YoY Change 11.73% 12.74%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $51.32M $42.93M
YoY Change 19.56% 44.04%
Depreciation, Depletion And Amortization $7.400M $7.400M
YoY Change 0.0% 17.46%
Cash From Operating Activities $18.10M $11.10M
YoY Change 63.06% -135.81%
INVESTING ACTIVITIES
Capital Expenditures -$10.00M -$11.00M
YoY Change -9.09% -20.29%
Acquisitions
YoY Change
Other Investing Activities $100.0K $100.0K
YoY Change 0.0% -88.89%
Cash From Investing Activities -$9.800M -$10.90M
YoY Change -10.09% -15.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -88.90M 5.700M
YoY Change -1659.65% -25.97%
NET CHANGE
Cash From Operating Activities 18.10M 11.10M
Cash From Investing Activities -9.800M -10.90M
Cash From Financing Activities -88.90M 5.700M
Net Change In Cash -80.60M 5.900M
YoY Change -1466.1% -116.3%
FREE CASH FLOW
Cash From Operating Activities $18.10M $11.10M
Capital Expenditures -$10.00M -$11.00M
Free Cash Flow $28.10M $22.10M
YoY Change 27.15% -228.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39977175 shares
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
325541000
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39977175 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39977175 shares
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
17570000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
55010000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
169405000
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18977000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-3742000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
1269584000
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
109170000
CY2014Q2 us-gaap Billings In Excess Of Cost
BillingsInExcessOfCost
69712000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1163758000
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
398000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1448560000
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9571000
CY2014Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
35555000
CY2014Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
8136000
CY2014Q2 us-gaap Liabilities
Liabilities
178976000
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q2 us-gaap Assets Current
AssetsCurrent
1121520000
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10752000
CY2014Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
95441000
CY2014Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
134042000
CY2014Q2 us-gaap Unbilled Receivables Not Billable At Balance Sheet Date Amount Expected To Be Collected Within One Year
UnbilledReceivablesNotBillableAtBalanceSheetDateAmountExpectedToBeCollectedWithinOneYear
43900000
CY2014Q2 us-gaap Assets
Assets
1448560000
CY2014Q2 us-gaap Noncurrent Assets
NoncurrentAssets
327040000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
342621000
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
316921000
CY2014Q2 us-gaap Inventory Net
InventoryNet
408066000
CY2014Q2 us-gaap Inventory Gross
InventoryGross
443621000
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
26613000
CY2014Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
27299000
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
214138000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
316288000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
257191000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40822627 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40822627 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23780000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
38801000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
142790000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21556000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-20170000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1242018000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
191965000
CY2013Q4 us-gaap Billings In Excess Of Cost
BillingsInExcessOfCost
45025000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1069816000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
407000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1394612000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9804000
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
33216000
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
13628000
CY2013Q4 us-gaap Liabilities
Liabilities
152594000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Assets Current
AssetsCurrent
1078813000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10993000
CY2013Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
85670000
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
119929000
CY2013Q4 us-gaap Unbilled Receivables Not Billable At Balance Sheet Date Amount Expected To Be Collected Within One Year
UnbilledReceivablesNotBillableAtBalanceSheetDateAmountExpectedToBeCollectedWithinOneYear
52900000
CY2013Q4 us-gaap Assets
Assets
1394612000
CY2013Q4 us-gaap Noncurrent Assets
NoncurrentAssets
315799000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
384356000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
279253000
CY2013Q4 us-gaap Inventory Net
InventoryNet
368354000
CY2013Q4 us-gaap Inventory Gross
InventoryGross
401570000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
21899000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
24951000
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
195971000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
304806000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.03
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40767000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
184000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.04
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
86101000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40583000 shares
us-gaap Revenues
Revenues
415186000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
58635000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-24134000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
349344000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
921000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1682000
us-gaap Interest Income Other
InterestIncomeOther
283000
us-gaap Operating Income Loss
OperatingIncomeLoss
108392000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
22000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
65842000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
108655000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15203000
us-gaap Net Income Loss
NetIncomeLoss
82769000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24658000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23101000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1326000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
299000
us-gaap Costs And Expenses
CostsAndExpenses
306794000
us-gaap Cost Of Services
CostOfServices
39546000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
209985000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9431000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1751000
us-gaap Share Based Compensation
ShareBasedCompensation
4136000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
68350000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-22802000
us-gaap Interest Expense
InterestExpense
20000
us-gaap Cost Of Revenue
CostOfRevenue
249531000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7749000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14353000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1682000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38902000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25886000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4380000
drq Engineering And Product Development
EngineeringAndProductDevelopment
18361000
drq Number Of Projects
NumberOfProjects
15 Project
drq Reporting Information Eliminations
ReportingInformationEliminations
-28306000
drq Percentage Of Product Revenue
PercentageOfProductRevenue
0.14 pure
drq Allocated Share Based Compensation Expense Capitalized
AllocatedShareBasedCompensationExpenseCapitalized
0
drq Percentage Of Cumulative Revenue
PercentageOfCumulativeRevenue
0.12 pure
drq Revenue From Inter Company Transactions
RevenueFromInterCompanyTransactions
28306000
dei Trading Symbol
TradingSymbol
DRQ
dei Entity Registrant Name
EntityRegistrantName
DRIL-QUIP INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001042893
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <i>Revenue Recognition</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"> <i>Product Revenue</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The Company earns product revenues from two methods:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">product revenues recognized under the percentage-of-completion method; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">product revenues from the sale of products that do not qualify for the percentage-of-completion method.</td> </tr> </table> </div>
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.31
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40723000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
222000 shares
us-gaap Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <i>Service revenue</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The Company earns service revenues from three sources:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">technical advisory assistance;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">rental of running tools; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">rework and reconditioning of customer-owned Dril-Quip products.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The Company does not install products for its customers, but it does provide technical advisory assistance. At the time of delivery of the product, the customer is not obligated to buy or rent the Company&#x2019;s running tools and the Company is not obligated to perform any subsequent services relating to installation. Technical advisory assistance service revenue is recorded at the time the service is rendered. Service revenues associated with the rental of running and installation tools are recorded as earned. Rework and reconditioning service revenues are recorded when the refurbishment process is complete.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The Company normally negotiates contracts for products, including those accounted for under the percentage-of-completion method, and services separately. For all product sales, it is the customer&#x2019;s decision as to the timing of the product installation as well as whether Dril-Quip running tools will be purchased or rented. Furthermore, the customer is under no obligation to utilize the Company&#x2019;s technical advisory services. The customer may use a third party or their own personnel.</p> </div>
us-gaap Revenue Recognition Percentage Of Completion Method
RevenueRecognitionPercentageOfCompletionMethod
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 0pt"> <i>Revenues recognized under the percentage-of-completion method</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The Company uses the percentage-of-completion method on long-term project contracts that have the following characteristics:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The contracts call for products which are designed to customer specifications;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The structural designs are unique and require significant engineering and manufacturing efforts generally requiring more than one year in duration;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The contracts contain specific terms as to milestones, progress billings and delivery dates; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Product requirements cannot be filled directly from the Company&#x2019;s standard inventory.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> For each project, the Company prepares a detailed analysis of estimated costs, profit margin, completion date and risk factors which include availability of material, production efficiencies and other factors that may impact the project. On a quarterly basis, management reviews the progress of each project, which may result in revisions of previous estimates, including revenue recognition. The Company calculates the percent complete and applies the percentage to determine the revenues earned and the appropriate portion of total estimated costs. Losses, if any, are recorded in full in the period they become known. Historically, the Company&#x2019;s estimates of total costs and costs to complete have approximated actual costs incurred to complete the project.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Under the percentage-of-completion method, billings may not correlate directly to the revenue recognized. Based upon the terms of the specific contract, billings may be in excess of the revenue recognized, in which case the amounts are included in customer prepayments as a liability on the Condensed Consolidated Balance Sheets. Likewise, revenue recognized may exceed customer billings in which case the amounts are reported in trade receivables. Unbilled revenues are expected to be billed and collected within one year. As of June&#xA0;30, 2014 and December&#xA0;31, 2013, receivables included $43.9 million and $52.9 million of unbilled receivables, respectively. For the quarter ended June&#xA0;30, 2014, there were 12 projects representing approximately 5% of the Company&#x2019;s total revenue and approximately 6% of its product revenues that were accounted for using percentage-of-completion accounting, compared to 11 projects during the second quarter of 2013, which represented approximately 6% of the Company&#x2019;s total revenues and approximately 7% of its product revenues. For the six months ended June&#xA0;30, 2014, there were 16 projects representing approximately 8% of the Company&#x2019;s total revenues and 10% of its product revenues, compared to 15 projects that represented approximately 12% of the Company&#x2019;s total revenues and 14% of its product revenues for the six months ended June&#xA0;30, 2013, all of which were accounted for using percentage-of-completion accounting.</p> </div>
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
66672000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40501000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <i>Use of Estimates</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Some of the Company&#x2019;s more significant estimates are those affected by critical accounting policies for revenue recognition, inventories and contingent liabilities as discussed more fully in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#xA0;31, 2013.</p> </div>
us-gaap Revenues
Revenues
434388000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
110370000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
16428000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
361915000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3460000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
251000
us-gaap Interest Income Other
InterestIncomeOther
349000
us-gaap Operating Income Loss
OperatingIncomeLoss
127521000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
149000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
72473000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
127858000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33272000
us-gaap Net Income Loss
NetIncomeLoss
93942000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32708000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
90022000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23218000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
24291000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
470000
us-gaap Costs And Expenses
CostsAndExpenses
306867000
us-gaap Cost Of Services
CostOfServices
40241000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
195539000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-88385000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2507000
us-gaap Share Based Compensation
ShareBasedCompensation
5660000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-41735000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-22748000
us-gaap Interest Expense
InterestExpense
12000
us-gaap Cost Of Revenue
CostOfRevenue
235780000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1386000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15126000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
251000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49455000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33916000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2726000
drq Number Of Service Revenue Sources
NumberOfServiceRevenueSources
3 Source
drq Engineering And Product Development
EngineeringAndProductDevelopment
21632000
drq Number Of Projects
NumberOfProjects
16 Project
drq Number Of Product Revenue Sources
NumberOfProductRevenueSources
2 Method
drq Number Of Geographic Segments
NumberOfGeographicSegments
3 Segment
drq Reporting Information Eliminations
ReportingInformationEliminations
-25184000
drq Percentage Of Product Revenue
PercentageOfProductRevenue
0.10 pure
drq Allocated Share Based Compensation Expense Capitalized
AllocatedShareBasedCompensationExpenseCapitalized
0
drq Percentage Of Cumulative Revenue
PercentageOfCumulativeRevenue
0.08 pure
drq Revenue From Inter Company Transactions
RevenueFromInterCompanyTransactions
25184000
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1602 shares
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.05
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40821000 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
185000 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.06
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40636000 shares
CY2013Q2 us-gaap Revenues
Revenues
222031000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33416000
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-9511000
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
188859000
CY2013Q2 us-gaap Interest Income Other
InterestIncomeOther
167000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
56215000
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
33172000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
56376000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
42927000
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
165816000
CY2013Q2 us-gaap Cost Of Services
CostOfServices
19891000
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
113312000
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2000000
CY2013Q2 us-gaap Interest Expense
InterestExpense
6000
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
235000 shares
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.27
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40327000 shares
CY2014Q2 us-gaap Revenues
Revenues
230315000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
62023000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
68954000
CY2014Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
40401000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
69215000
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
10699000
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
189914000
CY2014Q2 us-gaap Interest Income Other
InterestIncomeOther
266000
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
133203000
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23273000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13449000
CY2013Q2 drq Engineering And Product Development
EngineeringAndProductDevelopment
9340000
CY2013Q2 drq Number Of Projects
NumberOfProjects
11 Project
CY2013Q2 drq Reporting Information Eliminations
ReportingInformationEliminations
-15633000
CY2013Q2 drq Percentage Of Product Revenue
PercentageOfProductRevenue
0.07 pure
CY2013Q2 drq Allocated Share Based Compensation Expense Capitalized
AllocatedShareBasedCompensationExpenseCapitalized
0
CY2013Q2 drq Percentage Of Cumulative Revenue
PercentageOfCumulativeRevenue
0.06 pure
CY2013Q2 drq Revenue From Inter Company Transactions
RevenueFromInterCompanyTransactions
15633000
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.27
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40562000 shares
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
51324000
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
161361000
CY2014Q2 us-gaap Cost Of Services
CostOfServices
20785000
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
104208000
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2800000
CY2014Q2 us-gaap Interest Expense
InterestExpense
5000
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
124993000
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25520000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17891000
CY2014Q2 drq Engineering And Product Development
EngineeringAndProductDevelopment
10848000
CY2014Q2 drq Number Of Projects
NumberOfProjects
12 Project
CY2014Q2 drq Reporting Information Eliminations
ReportingInformationEliminations
-13350000
CY2014Q2 drq Percentage Of Product Revenue
PercentageOfProductRevenue
0.06 pure
CY2014Q2 drq Allocated Share Based Compensation Expense Capitalized
AllocatedShareBasedCompensationExpenseCapitalized
0
CY2014Q2 drq Percentage Of Cumulative Revenue
PercentageOfCumulativeRevenue
0.05 pure
CY2014Q2 drq Revenue From Inter Company Transactions
RevenueFromInterCompanyTransactions
13350000

Files In Submission

Name View Source Status
0001193125-14-285005-index-headers.html Edgar Link pending
0001193125-14-285005-index.html Edgar Link pending
0001193125-14-285005.txt Edgar Link pending
0001193125-14-285005-xbrl.zip Edgar Link pending
d739893d10q.htm Edgar Link pending
d739893dex101.htm Edgar Link pending
d739893dex311.htm Edgar Link pending
d739893dex312.htm Edgar Link pending
d739893dex321.htm Edgar Link pending
d739893dex322.htm Edgar Link pending
drq-20140630.xml Edgar Link completed
drq-20140630.xsd Edgar Link pending
drq-20140630_cal.xml Edgar Link unprocessable
drq-20140630_def.xml Edgar Link unprocessable
drq-20140630_lab.xml Edgar Link unprocessable
drq-20140630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending